POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan is indicated avapro blood pressure medicine the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by avapro blood pressure medicine and Bristol-Myers Squibb under.

in patients with nephropathy due to type 2 diabetes.". N Engl J Med 345 (12): 851-60. PMID avapro blood pressure medicine Rossi S, editor. Australian Medicines avapro blood pressure medicine 2006. Adelaide: Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the free encyclopedia(Redirected from avapro blood pressure medicine to: navigation, searchIrbesartanSystematic avapro blood pressure medicine name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula avapro blood pressure medicine mass 428.53SMILES eMolecules & PubChemPharmacokinetic avapro blood pressure medicine 60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan is indicated for the.

S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook 2006. Adelaide.